The role of gut microbiota dysbiosis in drug-induced brain injury: mechanisms and therapeutic implications
Drug-induced brain injury (DIBI) results from toxicity, interactions or misuse and is increasingly linked to gut-microbiota dysbiosis operating via the gut–brain axis. Disturbed microbial balance drives three core mechanisms—oxidative stress, neuroinflammation and metabolic dysfunction—leading to bl...
Saved in:
| Main Authors: | Jinghui Zhai, Yue Zhang, Shuyue Ma, Yingli Zhang, Miao Jin, Huiyu Yan, Sixi Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1604539/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota-mediated pain sensitization: mechanisms and therapeutic implications
by: Minghe Zhao, et al.
Published: (2025-07-01) -
Gut Microbiota and Alzheimer Disease
by: Lester Raymundo Dominguez Huarcaya
Published: (2025-01-01) -
The role of microbiota dysbiosis in Parkinson’s disease: Pathophysiology and therapeutic opportunities
by: Shabnam Santos, et al.
Published: (2025-09-01) -
From gut to brain: exploring the impact of microbiota, dysbiosis, and neuroinflammation in neurodegenerative disorders
by: A. Deevan Paul, et al.
Published: (2025-08-01) -
Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials
by: Kelly Jimin Park, et al.
Published: (2024-10-01)